Biosino Bio-Technology and Science Incorporation (HKG:8247)
3.480
+0.020 (0.58%)
At close: Apr 20, 2026
HKG:8247 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 43.52 | 68.21 | 63.41 | 77.35 | 44.47 |
Short-Term Investments | 0.86 | 6.75 | 8.68 | 6.96 | 6.27 |
Cash & Short-Term Investments | 44.38 | 74.96 | 72.09 | 84.31 | 50.74 |
Cash Growth | -40.80% | 3.98% | -14.49% | 66.17% | -7.82% |
Accounts Receivable | 106.68 | 121.54 | 179.8 | 215.51 | 207.44 |
Receivables | 137.78 | 152.7 | 212.45 | 246.67 | 241.87 |
Inventory | 43.61 | 53.76 | 60.41 | 55.49 | 60 |
Other Current Assets | 4.24 | 3.98 | 5.18 | 11 | 55.47 |
Total Current Assets | 230 | 285.41 | 350.14 | 397.46 | 408.08 |
Property, Plant & Equipment | 61.49 | 74.55 | 83.68 | 85.17 | 106.84 |
Long-Term Investments | 74.44 | 74.66 | 78.45 | 66.1 | 60.81 |
Other Intangible Assets | 13.79 | 18.69 | 20.45 | 23.36 | 22.3 |
Long-Term Accounts Receivable | 0.5 | 0.5 | 0.5 | 2.7 | 0.77 |
Long-Term Deferred Tax Assets | 9.36 | 5.37 | 3.23 | 3.93 | 3.49 |
Long-Term Deferred Charges | - | - | 6.09 | 3.08 | 4.88 |
Other Long-Term Assets | 17.55 | 18.2 | 20.71 | 21.44 | 0.6 |
Total Assets | 407.12 | 477.37 | 563.25 | 603.24 | 607.76 |
Accounts Payable | 62.67 | 87.11 | 111.54 | 137.01 | 145.67 |
Accrued Expenses | 16.71 | 21.12 | 28.55 | 31.2 | 25.72 |
Short-Term Debt | 97.87 | 91.86 | 107.75 | 102.55 | 152.57 |
Current Portion of Long-Term Debt | 54.03 | 51.8 | 32.99 | 31 | 9.18 |
Current Portion of Leases | 0.49 | 3.36 | 5.24 | 3.29 | 2.51 |
Current Income Taxes Payable | 0 | 0.01 | 0.22 | 3.47 | 3.47 |
Current Unearned Revenue | 10.01 | 6.74 | 12.24 | 11.63 | 16.75 |
Other Current Liabilities | 38.63 | 30.89 | 22.23 | 26.11 | 33.17 |
Total Current Liabilities | 280.41 | 292.9 | 320.75 | 346.26 | 389.03 |
Long-Term Debt | 8.57 | 4.56 | 1.98 | 7.55 | 0.03 |
Long-Term Leases | 1.95 | 2.27 | 3.49 | 7.3 | 9.24 |
Long-Term Unearned Revenue | - | - | 0.07 | 0.83 | 2.46 |
Long-Term Deferred Tax Liabilities | 3.24 | 3.19 | 5.56 | 7.2 | 7.59 |
Total Liabilities | 294.17 | 302.91 | 331.85 | 369.14 | 408.35 |
Common Stock | 144.71 | 144.71 | 144.71 | 144.71 | 144.71 |
Retained Earnings | -167.7 | -116.55 | -74.02 | -62.37 | -70.48 |
Comprehensive Income & Other | 143.17 | 139.65 | 139.7 | 123.52 | 101.95 |
Total Common Equity | 120.18 | 167.81 | 210.39 | 205.85 | 176.17 |
Minority Interest | -7.23 | 6.66 | 21.02 | 28.26 | 23.24 |
Shareholders' Equity | 112.96 | 174.47 | 231.4 | 234.11 | 199.41 |
Total Liabilities & Equity | 407.12 | 477.37 | 563.25 | 603.24 | 607.76 |
Total Debt | 162.91 | 153.85 | 151.45 | 151.69 | 173.53 |
Net Cash (Debt) | -118.54 | -78.89 | -79.36 | -67.38 | -122.8 |
Net Cash Per Share | -0.82 | -0.55 | -0.55 | -0.47 | -0.85 |
Filing Date Shares Outstanding | 144.71 | 144.71 | 144.71 | 144.71 | 144.71 |
Total Common Shares Outstanding | 144.71 | 144.71 | 144.71 | 144.71 | 144.71 |
Working Capital | -50.4 | -7.49 | 29.39 | 51.2 | 19.05 |
Book Value Per Share | 0.83 | 1.16 | 1.45 | 1.42 | 1.22 |
Tangible Book Value | 106.4 | 149.12 | 189.94 | 182.49 | 153.88 |
Tangible Book Value Per Share | 0.74 | 1.03 | 1.31 | 1.26 | 1.06 |
Buildings | - | - | 40.9 | 40.9 | 62.93 |
Machinery | - | - | 222.26 | 225.77 | 211.41 |
Leasehold Improvements | - | - | 49.68 | 43.39 | 39.16 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.